Sunday June 22nd, 2014 20:54 Fibrocell Science, Inc. Announces Recognition for LAVIV™ (azficel-T) at The 2012 Cell & Gene Therapy Forum, Washington …

Fibrocell Science, Inc. , a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announces that the June 2011 FDA approval of LAVIV™ for the improvement of the appearance of “smile line” wrinkles was named the #3 top story of 2011 in cell and gene therapy and regenerative medicine at The 2012 Cell & Gene Therapy Forum …

Related Blogs

    Comment Form

    Your name

    Your email

    Your URL